Healthcare - Sector
KNSA is currently covered by 8 analysts with an average price target of $82.18. This is a potential downside of $11.72 (-12.48%) from yesterday's end of day stock price of $93.9.
Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 97 price targets and 89 ratings on display. The stock rating distribution of KNSA is 100% BUY.
Analysts' price targets on this stock were met 94.31% of the time, taking 620.5 days on average.
Highest price target for KNSA is $107, Lowest price target is $57, average price target is $82.18.
Most recent stock forecast was given by PAUL CHOI from GOLDMAN SACHS on 28-Oct-2026. First documented stock forecast 18-Jun-2018.
Currently out of the existing stock ratings of KNSA, 26 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jun-2020
$101
$7.1 (7.56%)
$90
24 days ago
(28-Oct-2026)
14/15 (93.33%)
$5.82 (6.11%)
866
Buy Since 18-Jun-2018
$102
$8.1 (8.63%)
$99
24 days ago
(28-Oct-2026)
19/21 (90.48%)
$6.82 (7.17%)
658
Buy Since 11-Mar-2019
$100
$6.1 (6.50%)
$60
3 months 23 days ago
(29-Jul-2026)
9/10 (90%)
$19.08 (23.58%)
796
Buy Since 18-Jun-2018
$107
$13.1 (13.95%)
$55
3 months 23 days ago
(29-Jul-2026)
12/13 (92.31%)
$26.08 (32.23%)
597
Buy Since 18-Feb-2026
$98
$4.1 (4.37%)
$64
3 months 23 days ago
(29-Jul-2026)
3/3 (100%)
$17.08 (21.11%)
99
What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on KNSA (Kiniksa Pharmaceuticals Ltd)?
Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?